Mark Wisniewski

Mark Wisniewski is a veteran financial and operational leader in the medical device industry, with senior roles spanning Boston Scientific, FARAPULSE, and other high-growth innovators. He currently serves as Chief Financial Officer of Enterra Medical, a commercial-stage company with an FDA-approved therapy for gastroparesis, and as Chairperson of the Board at Field Medical.

​

Throughout his 25+ year career, Mark has guided companies through financings, acquisitions, and commercialization milestones, partnering with leadership teams to develop strategic plans and advise on investment opportunities. He is recognized for his ability to identify and scale transformative technologies across the life sciences sector.

​

He holds a B.A. in Chemistry, a B.S. in Chemical Engineering, and an MBA.